Potent, selective, water-soluble benzodiazepine-based CCKB receptor antagonists that contain lipophilic carboxylate surrogates
- 19 October 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (20) , 2303-2308
- https://doi.org/10.1016/0960-894x(95)00399-e
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365,260, a Central Cholecystokinin Receptor Antagonist, in Patients With Panic DisorderArchives of General Psychiatry, 1994
- Synthetic Inhibitors of ElastaseMedicinal Research Reviews, 1994
- Second-Generation Benzodiazepine CCK-B Antagonists. Development of Subnanomolar Analogs with Selectivity and Water SolubilityJournal of Medicinal Chemistry, 1994
- High-Affinity and Potent, Water-Soluble 5-Amino-1,4-benzodiazepine CCKB/Gastrin Receptor Antagonists Containing a Cationic Solubilizing GroupJournal of Medicinal Chemistry, 1994
- L-708,474: The C5-cyclohexyl analogue of L-365,260, a selective high affinity ligand for the CCKB/gastrin receptorBioorganic & Medicinal Chemistry Letters, 1993
- Panic AttacksThe British Journal of Psychiatry, 1992
- Peptide leukotrienes: current status of researchJournal of Medicinal Chemistry, 1991
- Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic DisorderThe Canadian Journal of Psychiatry, 1990
- A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260European Journal of Pharmacology, 1989
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260Journal of Medicinal Chemistry, 1989